Phenomix Sciences

Phenomix Sciences is an early-stage healthcare solutions startup that aims to enable personalized management of chronic diseases with better efficacy, fewer side effects, and lower costs. Phenomix Sciences' approach is based on a phenotype-driven, multi-layer "omics" platform powered by deep learning technology to identify subtypes of chronic diseases, thereby personalizing treatment options and improving outcomes. The company's first product is a novel blood-based test, expected to launch in early 2020, which will accurately predict subtypes of obesity to guide the selection of appropriate therapies or medical interventions.